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Umbilical uptakes and transplacental concentration ratios of
amino acids in severe fetal growth restriction
Timothy R.H. Regnault1, Barbra de Vrijer2, Henry L. Galan3, Randall B. Wilkening1, Frederick C. Battaglia1 and Giacomo Meschia1
Background: This study examines the relationship
between placental amino acid (AA) transport and fetal AA
demand in an ovine fetal growth restriction (FGR) model in
which placental underdevelopment induces fetal hypoxemia
and hypoglycemia.
Methods: Umbilical uptakes of AA, oxygen, glucose, and
lactate were measured near term in eight experimental ewes
(FGR group) and in eight controls (C group).
Results: The FGR group demonstrated significantly reduced
umbilical uptakes of oxygen, glucose, lactate, and 11 AAs per
kg fetus. The combined uptake of glucose, lactate, and AAs,
expressed as nutrient/oxygen quotients, was reduced almost
to 1.00 (FGR: 1.05 vs. C: 1.32, P ≤ 0.02). In contrast to a decrease
in umbilical glucose concentration, all but one of the AAs that
were transported from placenta to fetus demonstrated normal
or elevated fetal concentrations, and five of the essential AAs
were transported against a significantly higher feto/maternal
(F/M) concentration ratio. This ratio peaked at the lowest fetal
oxygen levels.
Conclusion: We conclude that, in the hypoxic FGR fetus,
the reduction in AA uptake is not due to a disproportionally
small placental AA transport capacity. It is the consequence of
decreased fetal oxidative metabolism and growth rate, which
together reduce fetal AA demand.

I

n the second half of a normal pregnancy, a progressively larger
fraction of the placental barrier develops structural changes
that make it more permeable to the transplacental diffusion of
oxygen (1,2). In fetal growth restriction (FGR), both placental
growth and the process of differentiation that increases oxygen
diffusibility across the placenta are inhibited (3). As a consequence, the FGR placenta generates an abnormally large PO2
difference between uterine and umbilical venous blood (4,5).
In FGR, the transplacental glucose concentration difference is
also greater than normal (6,7) because placental glucose transport capacity is disproportionally reduced with respect to the
placental and fetal glucose utilization rates (7).
Tracer studies of placental amino acid (AA) transport have
demonstrated that in FGR, there is a significant reduction in the
transplacental flux/fetal turnover ratio of essential AAs (8–11).
However, attempts to define the fetal plasma AA concentrations

in FGR have produced inconclusive results. Although early
studies showed significantly lower concentrations (9,12,13),
subsequent human and animal studies could not confirm these
original findings (10,11). Hence, the extent to which the reduction in transplacental flux represents a dysfunction of placental
AA transport mechanisms and adaptation of these mechanisms
to a reduction in the fetal demand for AAs remains unclear. We
postulate that the variability in the degree of fetal hypoxia, which
is associated with FGR, is one of the factors that causes variabilities in fetal AA concentration. More specifically, we postulate
that fetal AA utilization depends on the availability of oxygen
and that in severely hypoxic FGR fetuses, the reduction in fetal
demand for AAs may become greater than the reduction in placental AA transport capacity.
This article presents the relation of umbilical AA uptake to
AA concentration and level of oxygenation in a sheep model
of severe FGR, in which uptakes and concentrations of oxygen, glucose, and lactate were measured simultaneously. Given
the magnitude and complexity of the study, a detailed analysis
of the results concerning placental oxygen transport has been
presented separately (5).
Results
In this article, the presentation of the O2 data is limited to what
is relevant to a discussion of AA transport and metabolism. The
FGR group produced significantly smaller placentae. Placental
and fetal weights were significantly correlated in the FGR group
but not in the control group (Figure 1). The mean umbilical AA
uptakes of the two groups are presented in Table 1. The uptakes
are presented as uptakes per kg fetus and as AA/oxygen molar
uptake ratios. In agreement with previous studies (14), there
was a positive umbilical uptake of all the essentials and of eight
nonessentials, a negative uptake of serine and glutamate, and
virtually no uptake of aspartate, citrulline, or taurine. With the
exception of lysine, the uptake per kg fetus of each essential was
significantly reduced in the FGR group, and there was a significant reduction in the uptake of each of three nonessentials:
arginine, tyrosine, and glutamine. The placental uptake of fetal
glutamate was significantly reduced.
Mean arterial and uterine venous AA concentrations are
presented in Table 2. In the FGR group, the mean maternal
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concentration of each AA was reduced. For 14 of these AAs,
both the arterial and venous reductions in concentration
were significant. Maternal plasma glucose was not significantly reduced (3.85 ± 0.12 vs. 3.87 ± 0.06 mmol/l). Mean
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Figure 1. In the fetal growth restriction (FGR) group, placental and fetal
weight are correlated (R2 = 0.88, P = 0.0005), whereas they are not for
control fetuses. (R2 = 0.01, P = 0.77). Control, filled squares; FGR, open
squares.
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umbilical venous and arterial AA concentrations are presented in Table 3. By contrast to the maternal data, only
isoleucine and glutamate showed a significant decrease in
arterial concentration, and six AAs: phenylalanine, lysine,
glycine, alanine, asparagine, and taurine showed a significant increase. For 12 of the 16 AAs with a positive umbilical
uptake, the arterial umbilical/maternal concentration ratio
was significantly higher in the FGR group (Table 4). These
data must be considered in conjunction with data on the
uptakes of O2, glucose, and lactate because the uptake per
kg fetus of these metabolites was also reduced (Table 5). The
reduction in fetal lactate uptake was associated with a significant increase in fetal lactate concentration (6.86 ± 1.74 vs.
1.93 ± 0.11 mmol/l, P = 0.01).
The absolute umbilical uptakes (µmol/min) of O2, glucose,
leucine, and lysine and the natural logs of the umbilical/uterine venous ratios of PO2, glucose, leucine, and lysine concentration are plotted against placental weight in Figure 2. Two
separate regression lines were calculated for the control and the
FGR uptake data. The FGR lines in the O2 and glucose uptake
graphs have significantly smaller intercepts (P < 0.05 and P <
0.0001, respectively) than the control lines, and no significantly
different slopes were observed. The FGR lines in the leucine

Table 1. Umbilical uptake of amino acids (µmol/min/(kgfetus)) and as amino acid/oxygen uptake molar ratio × 103
Control (µmol/min/(kgfetus))

FGR (µmol/min/(kgfetus))

P value

Control (molar ratio × 103)

FGR (molar ratio × 103)

P value

Val

4.66 ± 0.62

2.32 ± 0.20

0.003

13.81 ± 1.81

8.94 ± 0.88

0.03

Leu

4.26 ± 0.37

2.86 ± 0.13

0.003

12.49 ± 0.60

11.0 ± 0.66

NS

Ile

2.76 ± 0.30

1.59 ± 0.12

0.003

8.06 ± 0.53

6.14 ± 0.59

0.03

Thr

2.28 ± 0.35

1.27 ± 0.19

0.022

6.64 ± 0.82

4.79 ± 0.71

NS

Phe

1.51 ± 0.13

1.01 ± 0.10

0.008

4.49 ± 0.36

3.81 ± 0.34

NS

Met

1.07 ± 0.21

0.56 ± 0.07

0.036

3.09 ± 0.48

2.14 ± 0.27

NS

Lys

2.04 ± 0.22

1.75 ± 0.24

NS

6.00 ± 0.50

6.69 ± 0.87

NS

His

0.89 ± 0.15

0.54 ± 0.09

0.038

2.57 ± 0.25

2.03 ± 0.30

NS

Ser

−0.77 ± 0.53

−0.38 ± 0.22

NS

−2.15 ± 1.53

−1.50 ± 0.86

NS

Gly

2.89 ± 0.37

1.99 ± 0.26

NS

8.57 ± 1.03

7.64 ± 1.09

NS

Ala

2.65 ± 0.41

1.87 ± 0.23

NS

7.84 ± 1.23

7.25 ± 1.04

NS

Pro

2.31 ± 0.35

1.98 ± 0.39

NS

6.71 ± 0.90

7.76 ± 1.78

NS

Arg

2.16 ± 0.26

1.23 ± 0.16

0.009

6.39 ± 0.75

4.71 ± 0.62

NS

Orn

0.10 ± 0.14

0.06 ± 0.12

NS

0.36 ± 0.39

0.25 ± 0.45

NS

Tyr

1.43 ± 0.18

0.85 ± 0.10

0.014

4.42 ± 0.59

3.24 ± 0.38

NS

Essential

Nonessential

Gln

6.37 ± 0.71

3.50 ± 0.68

0.011

18.72 ± 1.69

13.37 ± 2.62

NS

Glu

−5.22 ± 0.72

−1.42 ± 0.17

0.001

−15.44 ± 1.93

−5.44 ± 0.67

0.001

Asn

1.24 ± 0.16

0.77 ± 0.33

NS

3.65 ± 0.42

2.80 ± 1.34

NS

Asp

0.02 ± 0.09

−0.04 ± 0.04

NS

−0.02 ± 0.27

−0.18 ± 0.16

NS

Cit

0.23 ± 0.19

0.00 ± 0.23

NS

0.69 ± 0.57

−0.02 ± 0.87

NS

Tau

0.08 ± 0.12

0.18 ± 0.19

NS

Data are means ± SEM for eight control and eight FGR ewes. NS, not significant (P > 0.05).
Ala, alanine; Arg, arginine; Asn, asparagine; Asp, aspartate; Cit, citrulline; FGR, fetal growth restriction; Gln, glutamine; Glu, glutamate; Gly, glycine; His, histidine; Ile, isoleucine; Leu,
leucine; Lys, lysine; Met, methionine; Orn, ornithine; Phe, phenylalanine; Pro, proline; Ser, serine; Tau, taurine; Thr, threonine; Tyr, tyrosine; Val, valine.
Copyright © 2013 International Pediatric Research Foundation, Inc.Volume 73 | Number 5 | May 2013      Pediatric Research
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Table 2. Maternal arterial and uterine venous concentrations of plasma amino acids (µmol/l) in the control and FGR groups
Control maternal artery

FGR maternal artery

P value

Control uterine vein

FGR uterine vein

P value

Val

325.79 ± 18.05

257.97 ± 35.21

NS

303.67 ± 18.55

245.99 ± 33.41

NS

Leu

230.14 ± 11.39

163.57 ± 16.69

0.005

212.26 ± 12.86

154.01 ± 15.80

0.02

Ile

169.37 ± 5.88

121.06 ± 12.54

0.004

155.99 ± 6.65

114.52 ± 11.83

0.02

Thr

222.31 ± 12.50

145.91 ± 20.96

0.007

209.63 ± 11.92

139.81 ± 19.92

0.02

Phe

71.35 ± 3.70

59.95 ± 4.57

0.03

69.05 ± 3.72

55.74 ± 4.32

0.04

Essential

Met

36.75 ± 1.30

23.31 ± 1.91

0.001

34.63 ± 1.47

22.01 ± 1.58

0.001

Lys

155.84 ± 8.99

109.61 ± 11.17

0.006

150.88 ± 10.79

105.81 ± 10.88

0.01

His

55.10 ± 3.04

47.21 ± 3.52

NS

52.85 ± 3.01

45.16 ± 3.26

NS

Nonessential
Ser

78.96 ± 2.65

62.50 ± 6.19

0.03

70.73 ± 2.57

57.70 ± 5.30

NS

Gly

415.58 ± 19.76

375.94 ± 14.61

NS

415.30 ± 17.44

381.57 ± 15.43

NS

Ala

135.86 ± 8.38

105.87 ± 8.81

0.03

130.30 ± 8.06

102.28 ±7.97

0.04

Pro

136.01 ± 11.34

70.15 ± 5.56

0.001

130.60 ± 9.65

69.48 ± 4.99

0.001

Arg

160.90 ± 18.42

126.53 ± 18.69

NS

152.63 ± 17.91

124.61 ± 18.39

NS

Orn

141.83 ± 11.55

103.21 ± 12.19

0.04

131.20 ± 11.17

99.93 ± 11.93

0.05

Tyr

86.15 ± 4.29

63.66 ± 7.12

0.02

83.59 ± 4.01

62.38 ± 6.85

0.01

Gln

256.70 ± 10.51

237.00 ± 12.05

NS

244.26 ± 8.42

224.90 ± 11.82

NS

Glu

78.03 ± 4.05

59.36 ± 5.10

0.01

78.73 ± 4.27

59.41 ± 5.36

0.03

Asn

50.51 ± 3.51

39.63 ± 3.66

NS

48.97 ± 2.85

32.30 ± 3.00

0.002

Asp

8.02 ± 0.49

6.13 ± 0.50

0.02

9.04 ± 0.66

6.99 ± 0.45

0.03

Cit

262.94 ± 34.27

192.67 ± 12.18

NS

249.89 ± 32.13

186.64 ± 12.03

0.03

Tau

73.31 ± 3.92

45.36 ± 6.72

0.003

73.65 ± 3.78

44.64 ± 5.84

0.001

Data are means ± SEM for eight control and eight FGR ewes. P determined by unpaired Student’s t-test. NS, not significant (P > 0.05).
Ala, alanine; Arg, arginine; Asn, asparagine; Asp, aspartate; Cit, citrulline; FGR, fetal growth restriction; Gln, glutamine; Glu, glutamate; Gly, glycine; His, histidine; Ile, isoleucine; Leu,
leucine; Lys, lysine; Met, methionine; Orn, ornithine; Phe, phenylalanine; Pro, proline; Ser, serine; Tau, taurine; Thr, threonine; Tyr, tyrosine; Val, valine.

and lysine uptake graphs have significantly smaller slopes than
the control lines (P < 0.02 for leucine and P < 0.002 for lysine).
Polynomial analysis was used to construct the curves relating the natural log of the transplacental concentration ratio to
placental mass. These curves have a descriptive purpose and
are not derived from a theoretical model. The small number of
observations did not allow us to establish whether the control
and FGR ratios fit two separate curves. The four upper panels
of Figure 2 show that as placental weight decreased, it took
progressively larger transplacental PO2 and glucose concentration gradients to draw progressively smaller amounts of oxygen and glucose into the umbilical circulation. In association
with a decrease in placental weight from about 500 to 100 g,
umbilical venous PO2 decreased from a maximum of 70% of
uterine venous PO2 (ln 0.7 = −0.36) to a minimum of 25% (ln
0.25 = −1.39). The umbilical venous glucose decreased from a
maximum of 40% to a minimum of 12% of the uterine venous
glucose concentration. The four lower panels of Figure 2 show
that in the FGR group, the decline in placental weight and in
the umbilical uptakes of leucine and lysine was associated with
an increase in the feto/maternal concentration ratio of these
two AAs. This is in contrast to the decline in the PO2 and glucose feto/maternal ratios.
604 Pediatric Research      Volume 73 | Number 5 | May 2013

The decrease in umbilical venous PO2 was associated with
a decrease in umbilical blood flow (5), and led to extremely
low values of umbilical arterial O2 content for five of the eight
FGR fetuses (O2 content < 1 mmol/l). The natural log of the
umbilical/maternal arterial concentration ratio for each of the
essential AAs is plotted against umbilical arterial O2 content
in Figure 3. Arterial concentration ratios are used in these
graphs because they are plotted in relation to umbilical arterial O2 content. Polynomial analysis was used to construct the
curves in each panel. This figure demonstrates that for all these
essential AAs, the feto/maternal concentration ratio tends to
attain its highest value at the lowest O2 concentration.
Under normal physiologic conditions, the umbilical uptake
of nutrients has the two main functions of providing material
for the accretion of new tissue and providing metabolic fuels to
sustain fetal oxidative metabolism. Because in severe FGR the
fetal growth rate approaches zero, virtually all of the umbilical uptake of nutrients should be reduced to the single function of sustaining fetal O2 consumption. To explore the validity of this basic concept, the umbilical uptake of each of the
substrates that were measured in this study was transformed
into its umbilical nutrient/O2 quotient. The results of this
computation are presented in Table 6 and in the cumulative
Copyright © 2013 International Pediatric Research Foundation, Inc.
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Table 3. Umbilical venous and arterial plasma amino acid concentration (µmol/l) in the control and FGR group
Control umbilical vein

FGR umbilical vein

P value

Control fetal artery

FGR fetal artery

P value

Val

516.08 ± 29.57

457.07 ± 39.76

NS

481.94 ± 27.03

429.64 ± 39.75

NS

Leu

205.73 ± 11.30

222.77 ± 20.59

NS

174.49 ± 9.36

189.62 ± 19.92

NS

Ile

137.96 ± 8.12

110.94 ± 10.68

NS

117.47 ± 6.43

92.49 ± 9.61

0.05

Essential

Thr

330.97 ± 26.68

336.87 ± 25.26

NS

314.01 ± 27.91

322.53 ± 24.84

NS

Phe

116.43 ± 11.07

171.56 ± 14.30

0.009

105.21 ± 10.56

159.93 ± 14.72

0.01

Met

85.57 ± 4.39

74.41 ± 7.20

NS

77.80 ± 4.62

68.03 ± 6.65

NS

Lys

63.07 ± 8.19

133.83 ± 26.48

0.023

48.12 ± 7.34

113.98 ± 26.47

0.04

His

54.00 ± 3.33

70.68 ± 6.84

0.046

47.73 ± 3.38

65.75 ± 8.38

NS

Nonessential
Ser

689.29 ± 46.91

629.23 ± 91.65

NS

694.52 ± 47.35

633.51 ± 90.80

NS

Gly

370.55 ± 17.98

522.37 ± 61.21

0.032

349.51 ± 17.27

499.32 ± 60.04

0.031

Ala

296.85 ± 31.26

489.72 ± 83.88

0.049

277.58 ± 29.28

467.67 ± 82.65

0.048

Pro

173.33 ± 13.31

386.63 ± 117.77

NS

156.74 ± 11.44

363.35 ± 114.49

NS

Arg

76.61 ± 14.66

49.03 ± 7.96

NS

60.58 ± 13.48

34.56 ± 6.48

NS

Orn

68.18 ± 8.17

68.04 ± 7.64

NS

67.18 ± 7.97

67.36 ± 7.33

NS

Tyr

139.98 ± 10.64

164.10 ± 17.15

NS

128.78 ± 9.79

154.43 ± 17.37

NS

Gln

401.30 ± 22.84

474.20 ± 36.12

NS

354.98 ± 19.56

432.63 ± 38.06

NS

Glu

10.78 ± 2.29

12.89 ± 2.34

NS

48.42 ± 6.37

29.59 ± 3.73

0.023

Asn

48.23 ± 4.10

89.24 ± 14.57

0.017

39.09 ± 3.59

80.70 ± 16.56

0.028

Asp

19.50 ± 2.08

16.48 ± 1.68

NS

19.49 ± 2.02

16.94 ± 1.48

NS

Cit

162.51 ± 17.79

136.47 ± 12.29

NS

160.75 ± 17.00

136.83 ± 12.11

NS

Tau

77.85 ± 8.37

334.66 ± 66.59

0.002

77.07 ± 7.98

333.10 ± 65.37

0.002

Data are means ± SEM for eight control and eight FGR ewes. P determined by unpaired Student’s t-test. NS, not significant (P > 0.05).
Ala, alanine; Arg, arginine; Asn, asparagine; Asp, aspartate; Cit, citrulline; FGR, fetal growth restriction; Gln, glutamine; Glu, glutamate; Gly, glycine; His, histidine; Ile, isoleucine; Leu,
leucine; Lys, lysine; Met, methionine; Orn, ornithine; Phe, phenylalanine; Pro, proline; Ser, serine; Tau, taurine; Thr, threonine; Tyr, tyrosine; Val, valine.

graph of Figure 4. As expected, in the control group there was
a large surplus in the umbilical uptake of oxidizable substrates
(Table 6), providing the excess carbon and nitrogen required
for growth.
In the FGR group, the sum of all the umbilical O2 quotients
was ~1.0. This indicates that, on average, the fetal uptake of
carbon and nitrogen was just sufficient to meet oxidative
requirements. Of interest is the role that each substrate played
in this radically altered physiological state. The glucose/O2
quotient was not significantly different in the control and FGR
groups. There was, however, a disproportional decrease of the
umbilical lactate/O2 quotient. Despite the decrease in fetal O2
consumption, the umbilical uptake of glucose and lactate was
insufficient to sustain fetal oxidative metabolism. In this article, the lactate/O2 quotient calculation was based on plasma
lactate measurements and assumed zero lactate uptake by the
red cells (Φ = 1 in equation 3). The alternative calculation (Φ
= 0) yields lactate/O2 quotients equal to 0.21 ± 0.02 and 0.02 ±
0.08 for the control and FGR groups, respectively.
The umbilical uptake of AAs filled the gap in the availability of
oxidizable metabolites. Figure 4 shows that within the limits of
experimental error, the AAs with the largest uptake in the normal condition were also the ones that contributed most to the

metabolic balance of the FGR fetus. The mean placental uptake
of fetal glutamate in the FGR group was reduced to about 27%
of that of the control group and was significantly correlated
to the disproportionate decrease in the fetal liver/fetal weight
ratio that characterizes FGR (Figure 5). The uterine nutrient/
O2 quotient computation (Table 7) agrees with the umbilical
computation. It shows a surplus in the uptake of oxidizable substrates in the control group and no surplus in the FGR group.
From a methodological point of view, this agreement is an
important validation of the experimental results because the
calculation of the uterine and umbilical O2 quotients depends
on two sets of independent measurements. Note that the role
of each substrate in balancing supply and demand is somewhat
different across the uterine and the umbilical circulation. Both
circulations show the quantitatively important negative uptake
of one substrate that balances the positive uptake of all the other
substrates. However, in the uterine circulation, lactate, fulfills
this role and in the umbilical circulation, glutamate does. The
assumption that the maternal red cells did not pick up lactate
(Φ = 1) may have underestimated the uterine lactate excretion.
The alternative assumption (Φ = 0) would have increased the
uterine lactate excretion, expressed as lactate/O2 quotient by
0.04 for both the control and FGR groups.

Copyright © 2013 International Pediatric Research Foundation, Inc.Volume 73 | Number 5 | May 2013      Pediatric Research
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Table 4. Comparison of control vs. FGR of the umbilical arterial (α)/
maternal arterial (A) concentration ratios for the 16 amino acids with
a positive umbilical uptake and the 5 that did not display a positive
umbilical uptake
P value

Control α/A

FGR α/A

Val

1.49 ± 0.08

1.75 ± 0.14

NS

Leu

0.77 ± 0.05

1.20 ± 0.14

0.006

Ile

0.70 ± 0.04

0.80 ± 0.10

NS

Thr

1.41 ± 0.11

2.38 ± 0.24

0.002

Phe

1.46 ± 0.09

2.88 ± 0.30

0.001

Met

2.14 ± 0.15

3.08 ± 0.39

NS

Lys

0.30 ± 0.03

1.13 ± 0.31

0.001

His

0.85 ± 0.04

1.43 ± 0.18

0.004

Gly

0.85 ± 0.04

1.37 ± 0.20

0.031

Ala

2.07 ± 0.20

4.79 ± 1.00

0.009

Pro

1.18 ± 0.07

5.29 ± 1.62

0.001

Arg

0.37 ± 0.06

0.28 ± 0.04

NS

Orn

0.47 ± 0.03

0.69 ± 0.08

0.025

Tyr

1.49 ± 0.08

2.63 ± 0.41

0.009

Gln

1.38 ± 0.04

1.85 ± 0.17

0.018

Asn

0.77 ± 0.06

2.03 ± 0.37

0.001

Ser

8.83 ± 0.62

10.85 ± 1.96

NS

Glu

0.64 ± 0.09

0.50 ± 0.06

NS

Asp

2.48 ± 0.29

2.89 ± 0.30

NS

Cit

0.63 ± 0.04

0.71 ± 0.05

NS

Tau

1.07 ± 0.11

8.86 ± 2.24

0.001

Data are means ± SEM for eight control and eight FGR ewes. P determined by unpaired
Student’s t-test. NS, not significant (P > 0.05).
Ala, alanine; Arg, arginine; Asn, asparagine; Asp, aspartate; Cit, citrulline; FGR, fetal
growth restriction; Gln, glutamine; Glu, glutamate; Gly, glycine; His, histidine; Ile,
isoleucine; Leu, leucine; Lys, lysine; Met, methionine; Orn, ornithine; Phe, phenylalanine;
Pro, proline; Ser, serine; Tau, taurine; Thr, threonine; Tyr, tyrosine; Val, valine.

Table 5. Umbilical uptakes of oxygen, glucose, lactate, and total
amino acids in control and FGR fetuses (µmol/min/kgfetus)
Control
Oxygen

340.0 ± 23.3

FGR
261.6 ± 6.9

P value
0.006

Glucose

34.5 ± 2.9

25.5 ± 1.3

0.010

Lactate

16.4 ± 2.2

−1.2 ± 4.2

0.002

Amino acids

33.0 ± 4.0

22.5 ± 1.3

0.02

Data are means ± SEM for eight control and eight FGR ewes. P determined by unpaired
Student’s t-test. NS, not significant (P > 0.05).
FGR, fetal growth restriction.

Discussion
Human FGR is associated with abnormal development of the
placenta, with a decreased proportion of terminal villi relative
to stem and intermediate villi (3) and with asymmetric growth
of the fetus. FGR is a major cause of fetal and neonatal morbidity and mortality and is a major risk factor for cardiovascular
disease, type 2 diabetes mellitus, and obesity in adulthood (15).
The ovine FGR that is the subject of this investigation is also
characterized by asymmetrical fetal growth. It is characterized
606 Pediatric Research      Volume 73 | Number 5 | May 2013

by a reduction in placental weight, which is associated with
a disproportionate reduction in placental permeability to the
transplacental diffusion of oxygen and glucose. (Figure 2). A
significant enlargement of the transplacental PO2 and glucose
concentration differences has also been observed in human
FGR (4,6).
The primary focus of this study was to investigate the relative
importance of placental transport vs. fetal utilization in determining the umbilical uptake of AAs in the hypoxic growth-restricted fetus. One way to evaluate these factors is through use
of the AA fetal/maternal (F/M) concentration ratio. For any
given essential AA, for which uterine and umbilical uptakes
are virtually equal, the F/M ratio is an expression of the balance
between two factors: (i) the rate at which the placenta clears the
AA from the maternal circulation (placental transport clearance) and (ii) the rate at which fetal metabolism clears the AA
from the fetal circulation (fetal metabolic clearance). The uterine clearance (factor 1) is simply the uterine uptake of the AA
(Qut) divided by its maternal arterial concentration (A). Thus,
Qut/A = uterine clearance. The fetal clearance of the AA is the
umbilical uptake (Qft) divided by its fetal arterial concentration
(a). Thus, Qft/a = fetal clearance of the AA.
A decrease in fetal clearance tends to increase the F/M ratio,
whereas a decrease in placental transport clearance (uterine clearance) has the opposite effect. In the FGR group of
the current study, the F/M ratio of most of the AAs that are
transported by the placenta into the umbilical circulation was
significantly higher than in the control group (Table 2). This
finding indicates that the decrease in fetal clearance was the
dominant factor in limiting uptake.
Furthermore, for the two essential AAs leucine and lysine,
the F/M ratio showed a tendency to increase in an inverse
manner to placental weight and to umbilical uptake (Figure 2).
Therefore, the data in Figure 2, showing an increasing F/M
ratio with deceasing placental weight, lead to the conclusion
that at the lowest placental weight, the fetal ability to metabolize leucine and lysine had decreased even more than the ability
of the placenta to transport these AAs into the fetal circulation.
The evidence that the transplacental PO2 gradient is inversely
related to placental weight indicates fetal hypoxia as the condition that contributes to a decrease in the fetal plasma clearance
of AAs and causes the smallest FGR placentas to transport AAs
against higher F/M concentration ratios. Experiments in sheep
of graded fetal hypoxemia have shown that an umbilical arterial
content of about 2 mmol/l defines the threshold below which,
in the fetal lamb, the oxygen consumption of the organs perfused via the descending aorta begins to decrease. This decline
accelerates in inverse relation to O2 content so that below
the 1.5 mmol/l level oxygen uptake by the fetal hind limbs is
drastically reduced (16). In the current study, six of the eight
fetuses of the FGR group had an umbilical arterial O2 content
at or below 1.5 mmol/l. From 1.5 mmol/l downward, the F/M
ratio of all the essential AAs tended to increase in inverse relation to O2 content (Figure 3). This suggests that under significantly reduced oxygenation, an increased F/M ratio defines a
decreased clearance of AAs from fetal circulation.
Copyright © 2013 International Pediatric Research Foundation, Inc.
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Figure 2. Umbilical uptakes of oxygen, glucose, leucine, and lysine, and the natural log (ln) of the umbilical/uterine venous concentration ratios of these
metabolites are plotted against placenta weight. In the four left graphs, umbilical uptakes (µmol/min) of (a) O2, (c) glucose, (e) leucine, and (g) lysine. In
the four right graphs, the ln of the (b) PO2, (d) glucose, (f) leucine, and (h) lysine ratios. Polynomial analysis was used to draw the curves in these graphs.
Two separate regression lines were calculated for the FGR and control uptakes. Control, filled squares; FGR, open squares. The horizontal dotted line in
graphs f and h defines a fetal/maternal concentration ratio of one. FGR, fetal growth restriction.

Variability in the degree of fetal hypoxemia may be one of
the reasons why a low concentration of fetal plasma AAs is
not a standard feature of FGR. In a previous study of ovine
FGR, fetal plasma leucine was significantly lower than in controls and consistently lower than maternal leucine (9). This
contrasts with the data in the current study, which show no
significant decrease in the mean FGR fetal leucine concentration and a reversal of the mean F/M leucine ratio from <1 in
the control group to >1 in the FGR group. A major difference
between the two studies is that, in the tracer leucine study, the
mean FGR umbilical arterial O2 content was much higher than

that in the current study (2.4 vs. 1.2 mmol/l). This higher level
of oxygenation was associated with higher umbilical uptakes of
O2, glucose, and leucine per kg fetus and with a positive rate of
fetal protein accretion (9).
The tracer leucine study demonstrated that in FGR, both
the flux of maternal leucine into the fetus and the back-flux
of fetal leucine into the placenta were reduced in relation to
placental and fetal weight and that the back-flux correlated
with fetal plasma leucine concentration (9). This evidence supports the hypothesis that placental underdevelopment causes
FGR by limiting the transport of maternal AAs into the fetal
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Figure 3. The natural log (ln) of the umbilical arterial/uterine arterial concentration ratio for essential amino acids is plotted against the umbilical arterial
O2 content (mmol/l). (a) Lys, (b) Leu, (c) Val, (d) Ile, (e) Thr, (f) Phe, (g) Met, (h) His. Polynomial analysis was used to construct the curves that are drawn
through the data. Control, filled squares; fetal growth restriction, open squares. His, histidine; Ile, isoleucine; Leu, leucine; Lys, lysine; Met, methionine;
Phe, phenylalanine; Thr, threonine; Val, valine.

Table 6. Umbilical uptakes of glucose, lactate, and total amino acids
expressed as nutrient/O2 quotients and their sum in control and FGR
fetuses
Control

FGR

P value

Glucose

0.61 ± 0.03

0.59 ± 0.03

NS

Lactate

0.14 ± 0.02

−0.02 ± 0.05

0.01

Amino acids

0.56 ± 0.05

0.48 ± 0.03

NS

Sum

1.32 ± 0.08

1.05 ± 0.06

0.017

Data are means ± SEM for eight control and eight FGR ewes. P determined by unpaired
Student’s t-test. NS, not significant (P > 0.05).
FGR, fetal growth restriction.

circulation. However, a subsequent study, which was focused
on the investigation of hepatic metabolism in a normally grown
fetus, produced the unexpected result that a 20-h infusion of
a glucagon-somatostatin solution into the fetal circulation
inhibits the placental transport of both neutral and basic AAs
(17). This finding indicates that hormonal mechanisms, which
regulate fetal metabolism, are also important in the regulation
608 Pediatric Research      Volume 73 | Number 5 | May 2013

of placental AA transport. Thus, an alternative hypothesis is
that in FGR, these mechanisms adapt fetal growth to placental underdevelopment via a downregulation of placental AA
transport.
One of the main functions of placental AA transport is to
supply the fetus with substrates of oxidative metabolism, even
in severe FGR. This is a quantitatively important function, as
demonstrated by the finding that in the FGR group of the current study, despite evidence of virtually zero growth (Figure 4),
the umbilical uptake of AAs per kg fetus was reduced only to
~70% of normal (Table 5). The data in Table 5 suggest that this
relatively small decrease in AA uptake compensated for a large
deficit in umbilical lactate uptake.
Fetal AA oxidation in FGR may be accomplished in part via
the routing of AA carbon into fetal hepatic gluconeogenesis
and the subsequent oxidation of the produced glucose by other
fetal organs. An increase in fetal hepatic gluconeogenesis may
be one of the reasons why the fetal plasma glutamate concentration and the placental uptake of fetal glutamate were significantly reduced in the FGR fetuses (Tables 1 and 3). However,
Copyright © 2013 International Pediatric Research Foundation, Inc.
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Figure 4. Individual umbilical nutrient/O2 quotients were determined and
are presented as a cumulative graph comparing control (n = 8) (dashed
line) and FGR (n = 8) (solid line) umbilical nutrient/O2 quotients for all
the metabolites that were measured in this study. From left to right, the
quotients are ordered according to their magnitude in the control group.
The FGR quotients were significantly smaller for lactate, valine, isoleucine,
and glutamate (Tables 1 and 6). The sum of the FGR quotients was significantly less than control (1.05 vs. 1.32, P = 0.017) and approached the 1.00
level (dotted line) that defines zero growth. Ala, alanine; Arg, arginine; Asn,
asparagine; Asp, aspartate; Cit, citrulline; FGR, fetal growth restriction; Gln,
glutamine; Glu, glutamate; Gly, glycine; His, histidine; Ile, isoleucine; Leu,
leucine; Lys, lysine; Met, methionine; Orn, ornithine; Phe, phenylalanine;
Pro, proline; Ser, serine; Thr, threonine; Tyr, tyrosine; Val, valine.

Table 7. Uterine uptakes of glucose, lactate, and total amino acids
expressed as O2 quotients and their sum in control and FGR fetuses
Control

FGR

P value

Glucose

0.96 ± 0.09

0.74 ± 0.03

0.03

Lactate

−0.09 ± 0.01

−0.12 ± 0.02

NS

Amino acids

0.53 ± 0.09

0.32 ± 0.04

0.04

Sum

1.40 ± 0.15

0.94 ± 0.05

0.01

Data are means ± SEM for eight control and eight FGR ewes. P determined by unpaired
Student’s t-test. NS, not significant (P > 0.05).
FGR, fetal growth restriction.

the changes in fetal glutamate metabolism may have multiple
causes, including a decrease in the hepatic/fetal body mass
ratio (Figure 5) and fetal hepatic ischemia.
This study of AA uptake and utilization by growth-restricted
fetal lamb helps in interpreting data related to human FGR.
Clinical studies of FGR pregnancies have shown relationships
between placental weight and fetal weight similar to those
shown in Figure 1 (18). A significant relationship of placental weight and fetal oxygenation in human FGR has also
been demonstrated (8). Tracer studies of placental AA transport across the placenta of severely growth-restricted human
fetuses demonstrated that the transplacental fluxes of leucine
and phenylalanine were a smaller fraction of the fetal plasma
turnover of these AAs than in a normal pregnancy (8,10).
However, the umbilical venous concentration of these AAs was
not below normal (8,10). This result was puzzling because it

Figure 5. Placental glutamate uptake was significantly correlated (R2 =
0.67, P < 0.001) to the fetal liver/body weight ratio. Control, filled squares;
FGR, open squares. FGR, fetal growth restriction.

was contrary to the expectation that the availability of AAs for
fetal protein synthesis would be at its lowest level in the most
growth-restricted fetuses. Because these fetuses had a much
lower mean umbilical venous O2 saturation than the controls
(44.7 vs. 72.5%) and had an abnormally high impedance to
umbilical blood flow, it is likely that hypoxia had decreased
the clearance of AAs from the fetal circulation, resulting in
increased F/M ratios with decreased placental weights, which
is consistent with the findings of this study.
In conclusion, this study indicates that in the near term
growth-restricted fetus, impairment of placental O2 transport
may induce a state of severe hypoxia that in turn reduces the
ability of the fetus to utilize metabolic substrates. This reduction in metabolic rate may be disproportionally greater than
the reduction in placental AA transport capacity and may
produce the finding of normal, or even greater than normal,
fetal AA concentrations. It is important to note that severe fetal
hypoxia is not a constant aspect of FGR. According to studies
of human FGR, it may represent a late stage of this disease.
Therefore, the current study does not contradict the hypothesis that an impairment of placental AA transport may play
a crucial role in the development of FGR. Rather, it cautions
against the assumption that FGR is nothing more than a case
of nutrient deprivation.
Methods

Animal Care and Surgery
Sixteen time-mated 2–3-y-old Columbia-Rambouillet ewes pregnant
with a single fetus were studied as previously described (5). Animal
care was in compliance with US National Institutes of Health guidelines within an American Association for Accreditation of Laboratory
Animal Care–certified facility. The University of Colorado Health
Sciences Center Animal Care and Use Committee approved the study.
At ~38 d gestational age (dGA; term = 147 ± 3 dGA), the ewes were
allocated to either the thermoneutral control (C) or hyperthermic
(FGR) treatment, a treatment documented to induce placental insufficiency intrauterine growth restriction (5). Ewes in the FGR environment had their feed and water intakes recorded daily and were fed
a diet of alfalfa hay pellets. Control animals were fed the daily FGR
ewes’ intake. Ewes were maintained in the FGR environment until 120
± 1 dGA, after which they were moved to the control environment
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room where feeding continued ad libitum. The feed intake never fell
below 9.75 Mj/kg/d.
At 127 ± 1 dGA, ewes underwent surgery for placement of fetal
and maternal catheters as previously described (5). Following surgery, sheep were placed in individual carts with free access to water
and alfalfa hay pellets, and daily intakes were recorded. Ampicillin
(500 mg) was injected daily into the amniotic cavity for the first 3 d
after surgery. Animals were allowed to recover from surgery for at
least 5 d before study.
Study and Analytic Methods
At ~134 dGA, under control room conditions (19 ± 2 °C) and at animal core body temperature of ~39.1 °C, four sets of 1 ml blood samples were drawn at 20-min intervals, each set consisting of samples
drawn simultaneously from the maternal femoral artery, uterine vein,
umbilical vein, and fetal femoral artery. The fetal femoral arterial
and umbilical arterial blood had identical composition. A detailed
description and schematic drawing of this preparation has been published (19). The samples were analyzed for maternal and fetal PO2;
O2 saturation and O2 capacity; glucose, lactate, and AA concentrations; and the blood flow indicator (ethanol) (5). PO2 was measured
with a PO2 electrode (Radiometer America BMS 3 MK2, Westlake,
OH). Oxygen saturation and O2 capacity were measured spectrophotometrically (OSM2, Radiometer). Plasma glucose and lactate were
measured with a glucose-lactate analyzer (model 2700 Select and YSI
Dual Standard, Yellow Springs, Yellow Springs, OH). Ethanol was
measured enzymatically (Sigma Catalog no. Alcohol 332-UV, Sigma,
St Louis, MO).
Plasma AA determination was as previously described (14). Briefly,
on the day of analysis, samples were thawed quickly and deproteinized with 15% sulfosalicylic acid containing 0.3 μmol/l norleucine
as an internal standard. The pH was then adjusted to 2.2 with 1.5
N LiOH. After centrifugation, the supernatant was analyzed with a
Dionex (Dionex, Sunnyvale, CA) high-performance liquid chromatography AA analyzer. Concentrations were measured after reaction
with ninhydrin at 570 nm, except for proline, which was measured at
a wavelength of 440 nm. The same high-performance liquid chromatography column was used for all samples from an individual animal.
Reproducibility within the same column had a mean value of ±2%.
Calculations
The umbilical uptake of O2 (µmol/min) was calculated by means of
the equation:
  O2 umbilical uptake = f (γO2−αO2)(1)
where f is umbilical blood flow (ml/min) and γO2 and αO2 are
the O2 content (µmol/ml) in umbilical venous and umbilical arterial
blood, respectively.
The umbilical uptakes of the metabolic substrates that were measured in plasma (glucose, lactate, and AAs) were calculated by means
of the equation:
  (Umbilical uptake)x = f (γ−α)x (1−φxHtf)(2)
where (γ−a)x is the concentration difference per ml of plasma of
substrate x across the umbilical circulation (µmol/ml), Htf is the fractional hematocrit of fetal blood, and Φx is a coefficient whose value
depends on the contribution of fetal erythrocytes to uptake. The Φx
coefficient was set to 0.24 for glucose (7) and to 1.0 for AAs (14). The
value of Φx for lactate has not been determined. In this article, we set
Φx for lactate to 1. If there is rapid lactate exchange between plasma
and red cells, this calculation underestimates the true uptake.
The umbilical nutrient/O2 quotients were calculated according to
the equation:

(γ − α )x(1 − φx Htf )
(Umbilical nutrient/O2 quotient)x = (nO2 )x
(3)
γ O2 − α O2
where (nO2)x is the number of O2 molecules that are needed to oxidize one molecule of nutrient x to CO2, water, and urea. The uterine
nutrient/O2 quotients were similarly calculated.
610 Pediatric Research      Volume 73 | Number 5 | May 2013

For each nutrient, we computed the whole-blood arterial–venous
concentration difference across the uterine circulation and divided
this difference by the uterine oxygen (arterial–venous concentration)
difference. This molar ratio was then multiplied by the nO2 coefficient.
In the conversion of plasma to whole-blood concentration, the Φ
coefficient was set to 1.0 for AAs and lactate and to 0.87 for glucose.
The glucose Φ coefficient is much higher for maternal than fetal blood
because in adult sheep, most of the blood glucose is carried in the
plasma.
A goal of this study was to compare the changes in the transplacental concentrations of metabolites as diverse as free oxygen, glucose, and AAs. In ovine FGR, there is an enlargement of the uterine venous–umbilical venous PO2 difference (5) and of the maternal
arterial–umbilical arterial plasma glucose concentration difference
(7). Studies of AA transport across the FGR placenta have described
changes in the umbilical venous/maternal arterial concentration
ratios (10,12). In comparing transplacental PO2, glucose, and AA concentrations in any given animal, it is necessary to compare samples
that have been drawn from the same vessel, and it is preferable to
avoid the difficulty of comparing differences with ratios. This is one
of the reasons to use the natural logs of the umbilical/uterine venous
PO2, plasma glucose, and plasma AA ratios for a direct comparison
of concentration changes (Figure 2). A second reason is that this log
transformation focuses attention on the energetics of placental transport. The umbilical uptake of O2 and glucose is energized by fetal
metabolism. As a consequence, the natural logs of the transplacental
feto/maternal PO2 and glucose concentration ratios are negative. The
umbilical uptake of AAs is energized both by placental metabolism
(active transport) and fetal metabolism (fetal consumption). As a
consequence, the natural log of the transplacental concentration ratio
of AAs can vary from negative to positive, depending on the balance
between placental active transport and fetal consumption.
Statistical Analysis
All data are presented as either mean ± SEM or as individual marks,
where n is the number per control or FGR group. For parameters
studies, a nonpaired t-test was used in the calculations for statistical differences between groups, dependent on normal distribution
of data. P < 0.05 was taken as the significance level. In some graphs,
visual inspection suggested a curvilinear relation between x and y.
For each of these graphs, polynomial analysis was used to construct a
descriptive curve. In all the other graphs, linear regression was used to
describe the y vs. x relation and to establish the significance (P < 0.05)
of slope and intercept.
ACKNOWLEDGMENTS
We are very grateful to Willie Jones, David Caprio and his laboratory staff,
I-Da and Yu-Ching Fan, and Alex Cheung for their technical support and Barbara Falk for her administrative support in preparing the manuscript.
Statement of Financial Support
T.R.H.R. and R.B.W. were supported by National Institute of Child Health and
Human Development at the US National Institutes of Health, grants PO1
HD20761 and RO1 HD41505; B.d.V. by the Ter Meulen Fund, Royal Dutch
Academy of Arts and Sciences; and H.L.G. by US National Institutes of Health
grant HL071990-01A1.
References
1. Castellucci M, Kosanke G, Verdenelli F, Huppertz B, Kaufmann P. Villous
sprouting: fundamental mechanisms of human placental development.
Hum Reprod Update 2000;6:485–94.
2. Meschia G. Placental respiratory gas exchange and fetal oxygenation. In:
Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore TR, eds. Creasy and
Resnik’s Maternal-Fetal Medicine: Principles and Practice, 6th edn. Philadelphia, Pennsylvania: Saunder Elsevier, 2009:181–91.
3. Jackson MR, Walsh AJ, Morrow RJ, Mullen JB, Lye SJ, Ritchie JW. Reduced
placental villous tree elaboration in small-for-gestational-age pregnancies:
relationship with umbilical artery Doppler waveforms. Am J Obstet Gynecol 1995;172(2 Pt 1):518–25.
Copyright © 2013 International Pediatric Research Foundation, Inc.

Umbilical amino acid uptake in FGR ovines
4.

Pardi G, Cetin I, Marconi AM, et al. Venous drainage of the human uterus:
respiratory gas studies in normal and fetal growth-retarded pregnancies.
Am J Obstet Gynecol 1992;166:699–706.
5. Regnault TR, de Vrijer B, Galan HL, Wilkening RB, Battaglia FC, Meschia
G. Development and mechanisms of fetal hypoxia in severe fetal growth
restriction. Placenta 2007;28:714–23.
6. Marconi AM, Paolini C, Buscaglia M, Zerbe G, Battaglia FC, Pardi G. The
impact of gestational age and fetal growth on the maternal-fetal glucose
concentration difference. Obstet Gynecol 1996;87:937–42.
7. Thureen PJ, Trembler KA, Meschia G, Makowski EL, Wilkening RB. Placental glucose transport in heat-induced fetal growth retardation. Am J
Physiol 1992;263(3 Pt 2):R578–85.
8. Marconi AM, Paolini CL, Stramare L, et al. Steady state maternal-fetal leucine enrichments in normal and intrauterine growth-restricted pregnancies. Pediatr Res 1999;46:114–9.
9. Ross JC, Fennessey PV, Wilkening RB, Battaglia FC, Meschia G. Placental
transport and fetal utilization of leucine in a model of fetal growth retardation. Am J Physiol 1996;270(3 Pt 1):E491–503.
10. Paolini CL, Marconi AM, Ronzoni S, et al. Placental transport of leucine,
phenylalanine, glycine, and proline in intrauterine growth-restricted pregnancies. J Clin Endocrinol Metab 2001;86:5427–32.
11. Anderson AH, Fennessey PV, Meschia G, Wilkening RB, Battaglia FC. Placental transport of threonine and its utilization in the normal and growthrestricted fetus. Am J Physiol 1997;272(5 Pt 1):E892–900.

Articles

12. Cetin I, Ronzoni S, Marconi AM, et al. Maternal concentrations and
fetal-maternal concentration differences of plasma amino acids in normal and intrauterine growth-restricted pregnancies. Am J Obstet Gynecol
1996;174:1575–83.
13. Economides DL, Nicolaides KH, Gahl WA, Bernardini I, Evans MI. Plasma
amino acids in appropriate- and small-for-gestational-age fetuses. Am J
Obstet Gynecol 1989;161:1219–27.
14. Chung M, Teng C, Timmerman M, Meschia G, Battaglia FC. Production
and utilization of amino acids by ovine placenta in vivo. Am J Physiol
1998;274(1 Pt 1):E13–22.
15. Ozanne SE, Constância M. Mechanisms of disease: the developmental origins of disease and the role of the epigenotype. Nat Clin Pract Endocrinol
Metab 2007;3:539–46.
16. Boyle DW, Hirst K, Zerbe GO, Meschia G, Wilkening RB. Fetal hind limb
oxygen consumption and blood flow during acute graded hypoxia. Pediatr
Res 1990;28:94–100.
17. Teng C, Battaglia FC, Meschia G, Narkewicz MR, Wilkening RB. Fetal
hepatic and umbilical uptakes of glucogenic substrates during a glucagonsomatostatin infusion. Am J Physiol Endocrinol Metab 2002;282:E542–50.
18. Marconi AM, Paolini CL, Zerbe G, Battaglia FC. Lactacidemia in intrauterine growth restricted (IUGR) pregnancies: relationship to clinical severity,
oxygenation and placental weight. Pediatr Res 2006;59(4 Pt 1):570–4.
19. Meschia G, Battaglia FC, Hay WW, Sparks JW. Utilization of substrates by
the ovine placenta in vivo. Fed Proc 1980;39:245–9.

Copyright © 2013 International Pediatric Research Foundation, Inc.Volume 73 | Number 5 | May 2013      Pediatric Research

611

